Varian Medical Systems, Inc. (NYSE:VAR) CAO Magnus Momsen sold 1,556 shares of the business’s stock in a transaction on Monday, March 12th. The shares were sold at an average price of $126.47, for a total transaction of $196,787.32. Following the sale, the chief accounting officer now directly owns 6,588 shares in the company, valued at $833,184.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Varian Medical Systems, Inc. (NYSE:VAR) remained flat at $$126.55 during trading hours on Monday. 400,509 shares of the company’s stock were exchanged, compared to its average volume of 749,387. Varian Medical Systems, Inc. has a twelve month low of $86.93 and a twelve month high of $130.29. The company has a market capitalization of $11,570.00, a PE ratio of 34.67, a price-to-earnings-growth ratio of 3.67 and a beta of 0.85.
Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings results on Wednesday, January 24th. The medical equipment provider reported $1.06 EPS for the quarter, beating the consensus estimate of $1.00 by $0.06. Varian Medical Systems had a net margin of 4.27% and a return on equity of 27.13%. The company had revenue of $678.50 million for the quarter, compared to analyst estimates of $633.96 million. During the same period in the prior year, the company earned $1.09 earnings per share. The firm’s revenue was up 12.8% on a year-over-year basis. equities analysts forecast that Varian Medical Systems, Inc. will post 4.31 EPS for the current fiscal year.
VAR has been the topic of a number of research analyst reports. Barrington Research raised shares of Varian Medical Systems from a “market perform” rating to an “outperform” rating and set a $130.00 price objective on the stock in a report on Thursday, January 25th. Royal Bank of Canada set a $105.00 price objective on shares of Varian Medical Systems and gave the company a “hold” rating in a report on Thursday, November 30th. Goldman Sachs Group lowered shares of Varian Medical Systems from a “neutral” rating to a “sell” rating and set a $98.00 price target on the stock. in a report on Thursday, January 25th. TheStreet lowered shares of Varian Medical Systems from a “b+” rating to a “c” rating in a report on Monday, February 12th. Finally, Zacks Investment Research raised shares of Varian Medical Systems from a “sell” rating to a “hold” rating in a report on Monday, January 29th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the stock. Varian Medical Systems presently has a consensus rating of “Hold” and a consensus target price of $108.44.
ILLEGAL ACTIVITY WARNING: “Magnus Momsen Sells 1,556 Shares of Varian Medical Systems, Inc. (VAR) Stock” was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://www.americanbankingnews.com/2018/03/12/magnus-momsen-sells-1556-shares-of-varian-medical-systems-inc-var-stock.html.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.